Chymotrypsin
- Generic Name
- Chymotrypsin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9004-07-3
- Unique Ingredient Identifier
- BVS505O332
- Background
Chymotrypsin (EC 3.4.21.1) is a digestive enzyme that promotes proteolysis, or the breakdown of proteins and polypeptides. It is a serine protease synthesized in the pancreas and is a vital component in the pancreatic juice. Like most proteolytic enzymes, chymotrypsin is activated from its inactive zymogen precursor, chymotrypsinogen, in presence of Trypsin....
- Indication
No therapeutic indications.
- Associated Conditions
- Colorectal Cancer, Head & Neck Squamous Cell Carcinoma, Locally Advanced Cervical Cancer, Locally Advanced Non-Small Cell Lung Cancer, Multiple Myeloma (MM), Primary Non-metastatic Breast Cancer
- Associated Therapies
- -
Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- B.P. Koirala Institute of Health Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT06713733
- Locations
- 🇳🇵
Bp Koirala Institute of Health Sciences, Dharān Bāzār, Koshi, Nepal
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath